Disease | hemiplegia |
Phenotype | C0011847|diabetes |
Sentences | 3 |
PubMedID- 23378790 | The charlson comorbidity score is a composite index of comorbid health conditions, including myocardial infarction, heart failure, peripheral vascular disease, stroke, dementia, pulmonary disease, ulcer, liver disease, diabetes, diabetes with organ damage, hemiplegia, renal disease, severe liver disease, metastatic solid tumors, acquired immunodeficiency syndrome, cancer, and rheumatological disorders.10 all the factors were weighted 1 point with the exception of acquired immunodeficiency syndrome and metastatic solid tumors, which are weighted 6 points; cancer, severe renal disease, diabetes with end-organ damage, and hemiplegia weighted 2 points; and severe liver disease weighted 3 points. |
PubMedID- 21819551 | Comorbidities were identified according to the modified charlson index - the deyo index [25,26], using all hospital discharges in the years 2004-2005. we defined 16 categories (i.e., myocardial infarction, congestive heart failure, peripheral vascular disease, cerebrovascular disease, dementia, chronic pulmonary disease, rheumatologic disease, peptic ulcer disease, mild liver disease, moderate to severe liver disease, diabetes, diabetes with chronic complications, hemiplegia or paraplegia, renal disease, any malignancy including leukaemia and lymphoma, and acquired immunodeficiency syndrome). |
PubMedID- 24725511 | Deyo-charlson index consists of a weighted scale of 17 comorbidities (including myocardial infarction, congestive heart failure, peripheral vascular disease, cerebrovascular disease, dementia, chronic pulmonary disease, connective tissue disease, peptic ulcer disease, mild liver disease, diabetes, diabetes with end-organ damage, hemiplegia, moderate or severe renal disease, tumor without metastasis, leukemia, lymphoma, moderate or severe liver disease, metastatic solid tumor and aids), expressed as a summative score. |
Page: 1